Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01561989 · ClinicalTrials.gov registry record · NA
Cholecalciferol and Flu Vaccine in Treating Healthy Participants
A NA study, sponsored by Roswell Park Cancer Institute.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT01561989 is a NA study that was terminated before completion, run by Roswell Park Cancer Institute. The registered enrollment target is 11 participants.
The verdict
NCT01561989, a NA study, was terminated before completion, sponsored by Roswell Park Cancer Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This randomized clinical trial studies cholecalciferol and flu vaccine in treating healthy participants. Cholecalciferol may increase the immunologic response of flu vaccine in healthy participants. Flu vaccine may help the body build an immune response and help prevent flu
Interventions
- OTHER questionnaire administration
- BIOLOGICAL trivalent influenza vaccine
- DIETARY_SUPPLEMENT cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2011-10 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01561989
The ClinicalTrials.gov registry entry for NCT01561989 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which questionnaire administration is the first listed.
NCT01561989 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01561989 about?
NCT01561989 is a clinical study titled "Cholecalciferol and Flu Vaccine in Treating Healthy Participants". This randomized clinical trial studies cholecalciferol and flu vaccine in treating healthy participants. Cholecalciferol may increase the immunologic response of flu vaccine in healthy participants. Flu vaccine may help the body build an immune response and help prevent flu
What is the current status of trial NCT01561989?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2011-10. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01561989?
The interventions under investigation include: questionnaire administration (OTHER), trivalent influenza vaccine (BIOLOGICAL), cholecalciferol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01561989?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.